Evidence map›Paper›PMID 41654614›Full record

ArticleScientific reports2026

The antioxidant capacity and in-vitro anticancer effects of Artocarpus lakoocha Roxb. against laryngeal cancer cells.

Gökhan Kuran, Sibel Özdaş, Talih Özdaş, Ayşe Baldemir Kiliç, İpek Canatar

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gökhan KuranDepartment of Otolaryngology, Adana City Training and Research Hospital, Health Sciences University, Adana, Türkiye.ORCID http://orcid.org/0000-0002-0709-1887
Sibel ÖzdaşDepartment of Bioengineering, Faculty of Engineering, Adana Alparslan Türkeş Science and Technology University, Adana, Türkiye. sozdas@atu.edu.tr.ORCID http://orcid.org/0000-0003-4610-2785
Talih ÖzdaşDepartment of Otolaryngology, Adana City Training and Research Hospital, Health Sciences University, Adana, Türkiye.ORCID http://orcid.org/0000-0003-3651-1892
Ayşe Baldemir KiliçDepartment of Pharmaceutical Botany Faculty of Gülhane Pharmacy, Health Sciences University, Ankara, Türkiye.ORCID http://orcid.org/0000-0003-2473-4837
İpek CanatarDepartment of Bioengineering, Faculty of Engineering, Adana Alparslan Türkeş Science and Technology University, Adana, Türkiye.ORCID http://orcid.org/0000-0001-9448-8112

Funding

Health Sciences University Scientific Research Projects Coordination Unit 2022/136
6 · The paper itself

Abstract

Laryngeal cancer has a poor prognosis and invasive character. Despite recent technological advances, laryngeal cancer remains challenging with a low survival rate. Artocarpus lakoocha Roxb. (AL) is rich in oxyresveratrol with antioxidant, cytotoxic, and anti-inflammatory properties This study aimed to determine the total phenolic content, antioxidant capacity and in-vitro anticancer effects of AL on laryngeal cancer cell lines. Total phenolic content and antioxidant activity of AL was evaluated using Folin-Ciocalte and DPPH tests. Cytotoxic and antiproliferative effects were measured with MTT and live-dead assays, while CASP-3, BAX, and BCL-2 expressions were analyzed via qRT-PCR and western blotting. Cell migration inhibition was determined by scratch-wound healing assay. The total phenolic content of AL was calculated as 541.3 ± 14.1 mg gallic acid equivalent (GAE)/g. The IC

Indexed as

Antineoplastic Agents, PhytogenicAntioxidantsArtocarpusLaryngeal NeoplasmsPlant ExtractsApoptosisbcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell MovementCell ProliferationCell SurvivalHumansPhenolsAntineoplastic Agents, PhytogenicAntioxidantsbcl-2-Associated X ProteinCaspase 3PhenolsPlant ExtractsAntimigrativeAntioxidantArtocarpus lakoocha Roxb.CytotoxicityLaryngeal cancerProapoptotic

Identifiers

PMID41654614
PMCPMC12946323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.